White cell deficiency and TET2 and SRSF2 gene mutations

Authors

  • Bumbein Dashnyam Laboratory of Molecular Biology, Institute of Biology, Mongolian Academy of Sciences Ulaanbaatar, Mongolia

DOI:

https://doi.org/10.5564/pib.v38i1.2547

Keywords:

SRSF2 gene mutations

Abstract

No abstract in English

Цагаан эсийн дутагдал ба TET2, SRSF2 генийн мутаци

Abstract
76
PDF 74

References

V. Visconte, R. V. Tiu, and H. J. Rogers, “Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease,” Blood Res., vol. 49, no. 4, pp. 216–227, Dec. 2014, https://doi.org/10.5045/br.2014.49.4.216.

E. Papaemmanuil et al., “Clinical and biological implications of driver mutations in myelodysplastic syndromes,” Blood, vol. 122, no. 22, pp. 3616–3627, Nov. 2013, https://doi.org/10.1182/blood-2013-08-518886.

S. Jaiswal et al., “Age-related clonal hematopoiesis associated with adverse outcomes,” N. Engl. J. Med., vol. 371, no. 26, pp. 2488–2498, Dec. 2014, https://doi.org/10.1056/NEJMoa1408617.

Downloads

Published

2021-11-30

How to Cite

[1]
B. Dashnyam, “White cell deficiency and TET2 and SRSF2 gene mutations”, Proc. Inst. Biol., vol. 38, no. 1, pp. 193–196, Nov. 2021.

Issue

Section

Case Report

Categories